Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study.

ABSTRACT:

SUBMITTER: Saad F 

PROVIDER: S-EPMC9377412 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature